Free Trial

Martingale Asset Management L P Lowers Stock Holdings in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Martingale Asset Management L P decreased its position in shares of Genpact Limited (NYSE:G - Free Report) by 5.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 143,714 shares of the business services provider's stock after selling 7,884 shares during the quarter. Martingale Asset Management L P owned about 0.08% of Genpact worth $6,173,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. SRH Advisors LLC bought a new position in shares of Genpact during the 4th quarter worth about $26,000. Atlas Capital Advisors Inc. boosted its holdings in Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after acquiring an additional 216 shares in the last quarter. Manchester Capital Management LLC acquired a new position in shares of Genpact during the fourth quarter worth approximately $38,000. Smartleaf Asset Management LLC lifted its stake in shares of Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after buying an additional 783 shares in the last quarter. Finally, UMB Bank n.a. lifted its stake in shares of Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after buying an additional 433 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.

Wall Street Analyst Weigh In

G has been the subject of a number of analyst reports. Needham & Company LLC lifted their price target on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Mizuho upped their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and raised their price objective for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and upped their target price for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Six investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $48.44.

View Our Latest Stock Analysis on G

Insider Activity at Genpact

In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.80% of the stock is currently owned by company insiders.

Genpact Stock Performance

Shares of NYSE:G traded down $0.06 during midday trading on Tuesday, reaching $47.95. The company had a trading volume of 272,644 shares, compared to its average volume of 1,348,537. The stock has a market cap of $8.42 billion, a P/E ratio of 16.88, a P/E/G ratio of 1.84 and a beta of 1.06. The company's 50 day moving average price is $50.97 and its 200 day moving average price is $45.89. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $56.76.

Genpact (NYSE:G - Get Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, sell-side analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were issued a $0.17 dividend. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 annualized dividend and a yield of 1.42%. This is a positive change from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio (DPR) is 23.94%.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines